| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Prasugrel versus clopidogrel in patients with acute coronary syndromes.
|
N Engl J Med
|
2007
|
17.85
|
|
2
|
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
|
N Engl J Med
|
2015
|
13.90
|
|
3
|
Coronary intervention for persistent occlusion after myocardial infarction.
|
N Engl J Med
|
2006
|
8.74
|
|
4
|
Edoxaban versus warfarin in patients with atrial fibrillation.
|
N Engl J Med
|
2013
|
7.70
|
|
5
|
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.
|
Eur Heart J
|
2005
|
6.86
|
|
6
|
Effect of torcetrapib on the progression of coronary atherosclerosis.
|
N Engl J Med
|
2007
|
6.79
|
|
7
|
Apixaban with antiplatelet therapy after acute coronary syndrome.
|
N Engl J Med
|
2011
|
4.81
|
|
8
|
Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.
|
Eur Heart J
|
2003
|
4.70
|
|
9
|
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.
|
N Engl J Med
|
2012
|
4.49
|
|
10
|
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
|
Eur Heart J
|
2002
|
3.36
|
|
11
|
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.
|
Circulation
|
2013
|
3.25
|
|
12
|
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.
|
N Engl J Med
|
2011
|
3.20
|
|
13
|
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial.
|
JAMA
|
2008
|
3.09
|
|
14
|
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.
|
JAMA
|
2004
|
2.89
|
|
15
|
Gender differences in the management and clinical outcome of stable angina.
|
Circulation
|
2006
|
2.59
|
|
16
|
Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial.
|
Lancet
|
2013
|
2.22
|
|
17
|
Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial.
|
Circulation
|
2003
|
2.09
|
|
18
|
Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.
|
J Am Coll Cardiol
|
2005
|
1.92
|
|
19
|
Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians.
|
Eur Heart J
|
2008
|
1.80
|
|
20
|
Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial.
|
Circulation
|
2003
|
1.72
|
|
21
|
Prevalence and characteristics of coronary anomalies originating from the opposite sinus of Valsalva in 8,522 patients referred for coronary computed tomography angiography.
|
Am J Cardiol
|
2013
|
1.64
|
|
22
|
Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.
|
J Am Coll Cardiol
|
2006
|
1.64
|
|
23
|
The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina.
|
Eur Heart J
|
2005
|
1.64
|
|
24
|
Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study.
|
BMJ
|
2006
|
1.61
|
|
25
|
Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure.
|
J Am Coll Cardiol
|
2008
|
1.60
|
|
26
|
The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II).
|
Eur Heart J
|
2007
|
1.60
|
|
27
|
Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.
|
Circulation
|
2009
|
1.60
|
|
28
|
Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial.
|
JAMA
|
2013
|
1.45
|
|
29
|
Influence of different antiplatelet treatment regimens for primary percutaneous coronary intervention on all-cause mortality.
|
Eur Heart J
|
2009
|
1.41
|
|
30
|
Avoiding pacemaker lead entrapment during PFO closure.
|
Catheter Cardiovasc Interv
|
2008
|
1.38
|
|
31
|
PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study.
|
EuroIntervention
|
2010
|
1.34
|
|
32
|
The initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina.
|
Eur Heart J
|
2005
|
1.28
|
|
33
|
Public awareness of heart failure in Europe: first results from SHAPE.
|
Eur Heart J
|
2005
|
1.21
|
|
34
|
Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study.
|
Eur Heart J
|
2008
|
1.19
|
|
35
|
The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone.
|
Am Heart J
|
2011
|
1.12
|
|
36
|
NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study.
|
Circulation
|
2005
|
1.11
|
|
37
|
Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy.
|
Eur J Radiol
|
2009
|
1.11
|
|
38
|
Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial.
|
Eur Heart J
|
2010
|
1.10
|
|
39
|
Coronary computed tomographic angiography for prediction of procedural and intermediate outcome of bypass grafting to left anterior descending artery occlusion with failed visualization on conventional angiography.
|
Am J Cardiol
|
2012
|
1.05
|
|
40
|
Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial.
|
Am Heart J
|
2009
|
1.04
|
|
41
|
A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) Study.
|
J Am Coll Cardiol
|
2004
|
0.99
|
|
42
|
Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction.
|
Circulation
|
2011
|
0.96
|
|
43
|
The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable angina.
|
Eur Heart J
|
2006
|
0.95
|
|
44
|
Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial.
|
Circ Cardiovasc Interv
|
2009
|
0.92
|
|
45
|
Carotid intima-media thickness as a marker of cardiovascular risk in hypertensive patients with coronary artery disease.
|
Am J Hypertens
|
2007
|
0.90
|
|
46
|
Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial.
|
Circulation
|
2003
|
0.90
|
|
47
|
Comparison of usefulness of percutaneous coronary intervention guided by angiography plus computed tomography versus angiography alone using intravascular ultrasound end points.
|
Am J Cardiol
|
2011
|
0.90
|
|
48
|
Arrhythmogenic right ventricular cardiomyopathy in two pairs of monozygotic twins.
|
Int J Cardiol
|
2005
|
0.89
|
|
49
|
Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery.
|
Am Heart J
|
2009
|
0.89
|
|
50
|
Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.
|
Am Heart J
|
2004
|
0.87
|
|
51
|
Inadequate control of heart rate in patients with stable angina: results from the European heart survey.
|
Postgrad Med J
|
2010
|
0.87
|
|
52
|
Active lymphocytic myocarditis treated with murine OKT3 monoclonal antibody in a patient presenting with intractable ventricular tachycardia.
|
Tex Heart Inst J
|
2002
|
0.84
|
|
53
|
Electrophysiological effects of late percutaneous coronary intervention for infarct-related coronary artery occlusion: the Occluded Artery Trial-Electrophysiological Mechanisms (OAT-EP).
|
Circulation
|
2009
|
0.83
|
|
54
|
Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
|
Circ Cardiovasc Qual Outcomes
|
2011
|
0.82
|
|
55
|
Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years.
|
Am Heart J
|
2009
|
0.82
|
|
56
|
Comparison of invasive and non-invasive treatment strategies in older patients with acute myocardial infarction complicated by cardiogenic shock (from the Polish Registry of Acute Coronary Syndromes - PL-ACS).
|
Am J Cardiol
|
2011
|
0.81
|
|
57
|
Long term exercise capacity in patients with hypertrophic cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
|
Eur J Heart Fail
|
2008
|
0.80
|
|
58
|
Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy.
|
Trials
|
2013
|
0.79
|
|
59
|
Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease.
|
Am J Cardiol
|
2006
|
0.78
|
|
60
|
Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction.
|
Coron Artery Dis
|
2012
|
0.78
|
|
61
|
Sodium level on admission and in-hospital outcomes of STEMI patients treated with primary angioplasty: the ANIN Myocardial Infarction Registry.
|
Med Sci Monit
|
2009
|
0.78
|
|
62
|
Percutaneous revascularization and long term clinical outcomes of diabetic patients randomized in the Occluded Artery Trial (OAT).
|
Int J Cardiol
|
2013
|
0.78
|
|
63
|
Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT).
|
Am Heart J
|
2012
|
0.78
|
|
64
|
[Guidelines for percutaneous coronary interventions].
|
Rev Esp Cardiol
|
2005
|
0.77
|
|
65
|
Usefulness of 1H MR spectroscopy in the evaluation of myocardial metabolism in patients with dilated idiopathic cardiomyopathy: pilot study.
|
Acad Radiol
|
2003
|
0.77
|
|
66
|
Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial.
|
Am J Ther
|
2008
|
0.77
|
|
67
|
Infarct artery distribution and clinical outcomes in occluded artery trial subjects presenting with non-ST-segment elevation myocardial infarction (from the long-term follow-up of Occluded Artery Trial [OAT]).
|
Am J Cardiol
|
2013
|
0.77
|
|
68
|
The risk of non-sustained ventricular tachycardia after percutaneous alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
|
Clin Res Cardiol
|
2010
|
0.77
|
|
69
|
Increasing awareness and perception of heart failure in Europe and improving care--rationale and design of the SHAPE Study.
|
Cardiovasc Drugs Ther
|
2004
|
0.77
|
|
70
|
Late results of percutaneous balloon mitral commissurotomy in patients with restenosis after surgical commissurotomy compared to patients with 'de-novo' stenosis.
|
J Heart Valve Dis
|
2002
|
0.77
|
|
71
|
[Guidelines for percutaneous coronary interventions].
|
Ital Heart J Suppl
|
2005
|
0.77
|
|
72
|
Reduced kidney function estimated by cystatin C and clinical outcomes in hypertensive patients with coronary artery disease: association with homocysteine and other cardiovascular risk factors.
|
Kidney Blood Press Res
|
2010
|
0.77
|
|
73
|
Repeat percutaneous mitral balloon valvuloplasty for patients with mitral valve restenosis.
|
Catheter Cardiovasc Interv
|
2010
|
0.76
|
|
74
|
Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial).
|
Am J Cardiol
|
2005
|
0.76
|
|
75
|
Baseline clinical characteristics and midterm prognosis of STE-ACS and NSTE-ACS patients with normal coronary arteries.
|
Ann Noninvasive Electrocardiol
|
2009
|
0.76
|
|
76
|
Genetic variants in hypertensive patients with coronary artery disease and coexisting atheromatous renal artery stenosis.
|
Med Sci Monit
|
2008
|
0.76
|
|
77
|
Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT).
|
EuroIntervention
|
2009
|
0.75
|
|
78
|
Long-term outcomes after a strategy of percutaneous coronary intervention of the infarct-related artery with drug-eluting stents or bare metal stents vs medical therapy alone in the Occluded Artery Trial (OAT).
|
Am Heart J
|
2012
|
0.75
|
|
79
|
Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".
|
Circulation
|
2014
|
0.75
|
|
80
|
Coronary computed tomography angiography without catheter angiography before bypass surgery in a patient with diffuse aortic atherosclerosis.
|
J Thorac Imaging
|
2011
|
0.75
|
|
81
|
Differences in presentation and management of stable angina from East to West in Europe: a comparison between Poland and the UK.
|
Int J Cardiol
|
2007
|
0.75
|
|
82
|
Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock.
|
Crit Care Med
|
2014
|
0.75
|
|
83
|
Unexpected eosinophilic myocarditis in a young woman with rapidly progressive dilated cardiomyopathy.
|
Int J Cardiol
|
2002
|
0.75
|
|
84
|
Cardioverter-defibrillator lead-related thrombus treated with prolonged anticoagulation in patient with prothrombotic disorder.
|
Blood Coagul Fibrinolysis
|
2008
|
0.75
|
|
85
|
Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II).
|
EuroIntervention
|
2009
|
0.75
|
|
86
|
Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial.
|
Eur Heart J
|
2006
|
0.75
|
|
87
|
Computed tomography to predict surgical revascularization of a left anterior descending artery occlusion incompletely visualized by conventional angiography.
|
J Thorac Imaging
|
2012
|
0.75
|
|
88
|
Comparison of different methods of ST segment resolution analysis for prediction of 1-year mortality after primary angioplasty for acute myocardial infarction.
|
Ann Noninvasive Electrocardiol
|
2007
|
0.75
|